Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #51 to #100.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Targeted effects‏‎ (1 revision)
  2. Excess absolute risk‏‎ (1 revision)
  3. Exposure pathway‏‎ (1 revision)
  4. Typical value‏‎ (1 revision)
  5. Occupancy factor‏‎ (1 revision)
  6. Homologous recombination‏‎ (1 revision)
  7. Authorised discharge‏‎ (1 revision)
  8. ICRP Publication 101b‏‎ (1 revision)
  9. ICRP Publication 115‏‎ (1 revision)
  10. ICRP Publication 13‏‎ (1 revision)
  11. Clinical audit‏‎ (1 revision)
  12. Radon-prone area‏‎ (1 revision)
  13. ICRP Publication 144‏‎ (1 revision)
  14. Reference Person‏‎ (1 revision)
  15. ICRP Publication 19‏‎ (1 revision)
  16. Relative life lost‏‎ (1 revision)
  17. ICRP Publication 30 (Part 2)‏‎ (1 revision)
  18. ICRP Publication 99‏‎ (1 revision)
  19. ICRP Publication 4‏‎ (1 revision)
  20. Security screening‏‎ (1 revision)
  21. ICRP Publication 54‏‎ (1 revision)
  22. ICRP Publication 69‏‎ (1 revision)
  23. Stochastic effect‏‎ (1 revision)
  24. ICRP Publication 83‏‎ (1 revision)
  25. Tolerance dose‏‎ (1 revision)
  26. Acute exposure‏‎ (1 revision)
  27. Allometry‏‎ (1 revision)
  28. Potentially lethal damage repair‏‎ (1 revision)
  29. ICRP Publication 102‏‎ (1 revision)
  30. ICRP Publication 116‏‎ (1 revision)
  31. ICRP Publication 130‏‎ (1 revision)
  32. ICRP Publication 145‏‎ (1 revision)
  33. ICRP Publication 2‏‎ (1 revision)
  34. Relative risk‏‎ (1 revision)
  35. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  36. Ring chromosome‏‎ (1 revision)
  37. ICRP Supporting Guidance 2‏‎ (1 revision)
  38. ICRP Publication 40‏‎ (1 revision)
  39. ICRP Publication 55‏‎ (1 revision)
  40. Dose conversion convention‏‎ (1 revision)
  41. International Commission on Radiological Protection‏‎ (1 revision)
  42. ICRP Publication 7‏‎ (1 revision)
  43. Lag‏‎ (1 revision)
  44. ICRP Publication 84‏‎ (1 revision)
  45. Teratocarcinoma‏‎ (1 revision)
  46. Low dose‏‎ (1 revision)
  47. Exclusion‏‎ (1 revision)
  48. Α/β value‏‎ (1 revision)
  49. Oncogene‏‎ (1 revision)
  50. Biological half-life‏‎ (1 revision)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)